EAEman Abdelaziz

Eman Abdelaziz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eman Abdelaziz has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of the Potential Anti-Inflammatory Effect of a New Coumarin–Quinoline Hybrid in LPS-Induced Neuroinflammation

    by Omnia Hamdy Mohamed Shehata, Eman Abdelaziz, Hadeer Ali, Elshaymaa I. Elmongy, Reem Binsuwaidan, Wafaa M. Ibrahim, Sabreen El-Gamasy, Ibrahim El Tantawy El Sayed

    Background/Objectives: Neuroinflammation is characterized by the sustained activation of neuroglial cells, resulting in the production of cytokines and chemokines. It is associated with neurodegenerative processes. This study aims to assess the potential mitigating effect of a novel coumarin–quinoline hybrid by evaluating oxidative stress, apoptosis, and pyroptosis in an experimentally induced model of neuroinflammation. Methods: The study was conducted on 60 mice, allocated into six groups of ten: Group I served as the control; Group II received the new coumarin–quinoline hybrid; Group III received lipopolysaccharide (LPS); Group IV received LPS followed by the coumarin–quinoline hybrid; Group V received LPS followed by dexamethasone (DEX); and Group VI received LPS followed by the coumarin–quinoline hybrid and DEX. The model was validated by behavioral assessments, while oxidative stress was quantified via nitric oxide (NO), malondialdehyde (MDA) levels, superoxide dismutase (SOD) activity, apoptosis by caspase-3, and pyroptosis by NLRP3. Results: An anti-inflammatory effect of a new coumarin–quinoline hybrid, evidenced by decreased NLRP3 and NF-κB expression, reduced NO and MDA production, elevated SOD activity, and brought about suppression of caspase-3. Additionally, the newly formulated coumarin–quinoline hybrid demonstrated favorable ADMET characteristics, with in silico molecular studies indicating a stable energetic profile and dynamic equilibrium. Conclusions: Findings suggest that the new coumarin–quinoline hybrid holds significant potential as an adjuvant therapeutic option for neuroinflammation.


  • Performance assessment of coumarin–quinoline hybrid-loaded PVA/sodium alginate composite hydrogel membranes with dual anticancer and antimicrobial drug delivery potential

    by Elbadawy A. Kamoun, Eman Abdelaziz, Shahira H. El-Moslamy, Nihal Almuraikhi, Ezat A. Mersal, Amal F. Dawood, Tamer M. Shawky, Abrar Alanazi, Nashwa Almatrudi, Amr Negm, et al.

    Cancer is one of the major issues faced by the modern health system. Therefore, the development of new, safer and more efficient chemotherapeutics is of prime importance. Traditional cancer therapies, including chemotherapy, are flawed, with off-target and on-target toxicity effects on normal cells; thus, newer strategies to improve cell selective targeting are required. In the present study, a polyvinyl alcohol/sodium alginate membrane as a coumarin–quinoline delivery system was prepared and characterized. It exhibited promising activity against cancer cells with enhanced bioavailability and selectivity. This delivery system is known for its ability to minimize side effects on healthy cells. The coumarin–quinoline hybrid was easily synthesized in high yields via facile reactions of preprepared N1-(7-chloroquinolin-4-yl)propane-1,3-diamine (6) with coumarin-3-carbonyl chloride (3) in the presence of triethylamine at room temperature. The resultant coumarin–quinoline hybrid (CQ) was loaded onto hydrogel membranes made of poly(vinyl alcohol)/sodium alginate and encapsulated using a freeze–thaw method to form physically crosslinked chains. The results of cytotoxicity tests demonstrated that the prepared unloaded hydrogels exhibited cytotoxic effects against Vero cells, unlike control samples (100% cell viability recorded), with reduced cellular viabilities of 64–90%. The hydrogel formula (EA1-4) demonstrated the least cellular viability, while EA1-3 exhibited the highest cellular viability (Vero cells) among the unloaded hydrogels owing to the high SA contents in the membranes. The coumarin–quinoline hybrid-loaded membranes demonstrated a cellular viability of 62–84% owing to increasing coumarin–quinoline hybrid concentrations loaded in the hydrogels (EA2-1, EA2-2, EA2-3, and EA2-4), which decreased the viability of cells compared with CQ-free membranes. Specifically, cellular viability decreased upon increasing CQ concentration; thus, the EA2-4 formula (PVA/sodium alginate, 90 : 10%, 200 mg CQ) showed the highest activity. Statistical analysis of antimicrobial data showed that the EA2-4 formula offered the highest efficacy. After 42 hours of cultivation using the EA2-4 formula, the biofilm reduction percentages for Staphylococcus epidermidis (98.79 ± 2.67%), Staphylococcus aureus (94.96 ± 2.46%), and Bacillus cereus (97.96 ± 0.77%) significantly increased. The findings of this study suggest that the synthesized coumarin–quinoline hybrid-loaded members are good antimicrobial and anticancer biomaterials for versatile medical purposes.